Tracking the hidden cost of prostate cancer care
NCT ID NCT07460726
Summary
This study aims to understand how a standard combination treatment for prostate cancer—targeted radiation plus hormone-blocking therapy—affects men's sexual function. It will follow 130 men with a specific intermediate-risk prostate cancer, tracking changes in erectile function and other sexual health aspects over two years using questionnaires. The goal is to better inform patients about potential side effects of their cancer treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (ADENOCARCINOMA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Manitoba Prostate Centre
Winnipeg, Manitoba, R3E 0V9, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.